Galmed Pharmaceuticals is based in Ramat Gan, Israel. It has raised $6M in total funding. Latest round: Seed.
Galmed Pharmaceuticals funding overview
Galmed Pharmaceuticals is based in Ramat Gan, Israel. Galmed Pharmaceuticals has raised $6M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in June 2023. The round record for Galmed Pharmaceuticals runs through 2023; nothing later has been disclosed.
Galmed Pharmaceuticals at a glance
Total raised
$6M
Latest round
Seed
Latest round date
June 2023
Headquarters
Ramat Gan, Israel
Frequently asked about Galmed Pharmaceuticals funding
How much has Galmed Pharmaceuticals raised?
Galmed Pharmaceuticals has raised $6M in total disclosed funding across the rounds on record.
Who has invested in Galmed Pharmaceuticals?
No investors are named on the public record for Galmed Pharmaceuticals yet.
What was the latest Galmed Pharmaceuticals funding round?
The most recent disclosed round is a Seed, announced in June 2023.
Where is Galmed Pharmaceuticals based?
Galmed Pharmaceuticals is based in Ramat Gan, Israel.
When did Galmed Pharmaceuticals last raise?
The last disclosed Galmed Pharmaceuticals round closed in June 2023 at Seed.
We update the Galmed Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Ramat Gan and their backers are listed below.
